Brought to you by 
Ethicon buys ENT device maker Acclarent for $785mm in cash
Dec 2009
Executive Summary
Johnson & Johnson's Ethicon has acquired closely held Acclarent, a company developing minimally invasive ENT devices, for about $785mm in cash.
Deal Industry
-
Medical Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com